Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia

Lignende værker

• Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42()()
  af: Henderson, Sally E., et al.
  Udgivet: (2016)
• Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents
  af: Cheng, Hao, et al.
  Udgivet: (2016)
• Triological Society Thesis Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas
  af: Jacob, Abraham, et al.
  Udgivet: (2011)
• Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer
  af: Li, David R., et al.
  Udgivet: (2015)
• AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas
  af: Bush, Matthew L., et al.
  Udgivet: (2011)